Article: Geron and Exeter Life Sciences Merge Start Licensing and ViaGen to Form Combined Licensing and Operating Company for Animal Cloning Technologies.

Merger to Go Ahead as FDA Report Concludes That Food Products from Cloned Livestock and Their Offspring Are Safe

MENLO PARK, Calif. and PHOENIX, Ariz. -- Geron Corporation (Nasdaq:GERN) and Exeter Life Sciences, Inc. announced today the merger of Start Licensing, Inc. ("Start"), a joint venture between Geron and Exeter Life Sciences, and ViaGen, Inc., a subsidiary of Exeter Life Sciences.

Start manages and licenses a broad portfolio of intellectual property rights related to animal reproductive technologies, including animal cloning. ViaGen is a leading animal genomics and livestock cloning firm.

The merger of Start and ViaGen, combines the full breadth of ...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!